Venture investing provides the capital and management support necessary to assist entrepreneurs in transforming their ideas and innovative talents into unique products and services within a rapidly changing marketplace.
The dynamics of the healthcare landscape continue to provide opportunities to improve upon existing diagnostic, interventional and therapeutic modalities. Key developments such as the growing convergence between the biotechnology and medical device fields, as well as the growing application of information technology to the life sciences, have created numerous opportunities for entrepreneurs to develop ideas with the potential to transform medical practice.
At Oxford Bioscience Partners, we are committed to bringing short and long-term value to the companies in which we invest. We serve on Boards of Directors to assist management in creating and implementing their business and product development strategies, recruiting key executives, and undertaking additional financing initiatives. In addition, we have been particularly successful in facilitating corporate partnerships on a worldwide basis.
OBP has created a diverse deal pipeline, from multiple sources, that continuously supplies us with new investment opportunities. While we review hundreds of business plans annually, we select no more than a few of the strongest and most promising to become new OBP portfolio companies. We organize “think tanks” in emerging technology areas, bringing together panels of industry leaders, academic experts, and OBP professionals to explore the potential for creating a company based upon new scientific and technological developments. These think tanks have provided the inspiration for start-up companies in which OBP played a founding investor role. We typically make investments between $1,000,000 and $10,000,000 yet will also provide smaller amounts in the form of seed capital in select situations. Prior to investing, we work with the founders and management team, as well as with other venture capital investors to determine an optimal level of capitalization, and set a strategy for future financing activities. In most cases, we act as the lead investor to organize an appropriate syndicate of co-investors whose expertise and investment approach is aligned with our own. OBP provides equity financing to companies at all stages, and will consider almost all geographic locations.
Oxford Bioscience Partners focuses its investments in the areas of Medical Devices, R&D Instruments and Systems, Therapeutics, and companies with Breakthrough Technologies in the life sciences. Within each of these sectors we have defined an investment strategy that incorporates and capitalizes on the changes that have occurred both in the life science industries and in the post-bubble economy.
OBP has also invested in non-life science based technologies which have novel healthcare applications. The next ten years will bring numerous discoveries in science and medicine that will create opportunities for knowledgeable and qualified life science venture capital investors to earn extraordinary returns. We believe that Oxford Bioscience Partners is uniquely positioned to continue to lead the industry in creating valuable and important businesses and bringing the products of those businesses to the market.
Oxford Bioscience Partners Invests In These Industries
• Biotechnology
• Lifestyle
• Business Products and Services
• Marketing / Advertising
• Clean Technology
• Media and Entertainment
• Computers and Peripherals
• Medical Devices and Equipment
• Consumer Products and Services
• Mobile
• Education
• Nanotechnology
• Electronics / Instrumentation
• Networking and Equipment
• Financial Services
• Other
• Food / Drink
• Retailing / Distribution
• Gaming
• Semiconductors
• Healthcare Services
• Software
• IT Services
• Sports
• Industrial/Energy
• Telecommunications
• Internet / Web Services
• Travel
Oxford Bioscience Partners Invests In Companies That Have Reached The Following Milestones
$1M in Trailing 12 Mo. Revenue - $10M in Trailing 12 Mo. Revenue
Concept OnlyProduct In DevelopmentPrototype ReadyFull Product Ready$500K in Trailing 12 Mo. Revenue$1M in Trailing 12 Mo. Revenue$3M in Trailing 12 Mo. Revenue$5M in Trailing 12 Mo. Revenue$10M in Trailing 12 Mo. Revenue$20M in Trailing 12 Mo. Revenue$50M in Trailing 12 Mo. RevenueMore than $50M in Trailing 12 Mo. RevenueMore than $50M in Trailing 12 Mo. Revenue ►◄ Concept Only
Oxford Bioscience Partners Invests In Companies With These Funding Needs
Pre-money Valuation: $3,000,000 - $20,000,000
Capital Seeking: $1,000,000 - $10,000,000
Previously Raised: $500,000 - $5,000,000
Oxford Bioscience Partners Expects Their Investments To Generate
Expected Revenue By Year 5: $50,000,000 - $250,000,000
